Well-differentiated neuroendocrine tumors (NETs) of the stomach and pancreas represent 2 major subtypes of gastrointestinal NETs. Historically, there has been little consensus on the classification and management of patients with these tumor subtypes. We provide an overview of well-differentiated NETs of the stomach and pancreas and describe consensus guidelines for the treatment of patients with these malignancies. Copyright

, , , ,
doi.org/10.1097/MPA.0b013e3181ebb168, hdl.handle.net/1765/28073
Pancreas
Erasmus MC: University Medical Center Rotterdam

Kulke, M., Anthony, L., Bushnell, D., de Herder, W., Goldsmith, S., Klimstra, D., … Jensen, R. (2010). NANETS treatment guidelines: Well-differentiated neuroendocrine tumors of the stomach and pancreas. Pancreas (Vol. 39, pp. 735–752). doi:10.1097/MPA.0b013e3181ebb168